miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells

OBJECTIVE: The aim of the recent study was to investigate the effects of miR-205 on reversing Doxorubicin (DOX) resistance, as chemotherapeutic agents through up-regulation of PTEN in human liver cancer HepG2 cells. MATERIALS AND METHODS: In this experimental study, the drug resistance in liver canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mei, Li, Zhubin, Song, Juanrong, Li, Xu, Zhai, Pengtao, Mu, Xudong, Qiu, Fakai, Yao, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035231/
https://www.ncbi.nlm.nih.gov/pubmed/35451580
http://dx.doi.org/10.22074/cellj.2022.7231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035231/
https://www.ncbi.nlm.nih.gov/pubmed/35451580
http://dx.doi.org/10.22074/cellj.2022.7231

Ejemplares similares